| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $20.32B | $13.67B | $10.77B |
| YoY Revenue Growth % | +48.6% | +26.9% | — |
| Gross Profit | $4.19B | $2.88B | — |
| Gross Margin % | 20.6% | 21.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.88B | $990.0M | -$80.0M |
| Operating Margin % | 9.3% | 7.2% | -0.7% |
| Net Income (GAAP) | $1.41B | $210.0M | $450.0M |
| EBITDA (Normalized) | $2.00B | $1.06B | $307.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.04B | $918.0M | $803.0M |
| Capital Expenditures (CapEx) | $147.0M | $91.0M | $484.7M |
| Free Cash Flow (FCF) | $889.0M | $827.0M | $318.3M |
| FCF Margin % | 4.4% | 6.0% | 3.0% |
| Return on Invested Capital (ROIC %) | 25.0% | 16.3% | -0.3% |
| Cash & Short-Term Equivalents | $2.33B | $1.72B | — |
| Total Debt (Short + Long Term) | $4.83B | $5.26B | $9.70B |
| Total Stockholders' Equity | $3.44B | $1.26B | $19.90B |